DeepHealth, a global leader in AI-powered health informatics and a wholly owned subsidiary of RadNet, Inc. (NASDAQ: RDNT), today unveils at ECR 2026 the industry's most comprehensive portfolio of ...

The company's platform integrates genomic sequencing, clinical data analytics, and AI-driven insights across oncology, cardiology, and neuropsychiatry. Tempus serves more than 50% of U.S. oncologists ...

The AI medical imaging market is projected to hit nearly $20 billion by 2033, growing at a 34.7% CAGR([1]) . Echocardiography alone is forecast to grow to $2.64 billion by 2030 as hospitals demand ...

CAMC Urology recently performed his 100th robotic high intensity focused ultrasound (HIFU) procedure, an advanced treatment for patients with prostate cancer.

Based in Paris, France, Gleamer serves over 700 customer contracts worldwide with a broad portfolio of FDA-cleared and CE-marked solutions for ...

Global Urology Imaging Systems Market OverviewThe global urology imaging systems market is expected to register steady growth ...

Performed in a single session without any surgical incisions or scarring, the treatment utilizes an advanced fusion-guided system that combines magnetic resonance imaging (MRI) with precise prostate ...

Men with prostate cancer are being denied NHS access to a treatment used by Lord Cameron, a senior doctor has revealed.

A new study in Austria has shown that a special ultrasound treatment can effectively control early prostate cancer while helping men keep their quality of life. This method targets only the part of ...

The retrospective analysis included 1,119 men with MRI-visible prostate lesions who underwent prostate biopsy between 2019 and 2022. Of these, 767 received cognitively targeted micro-ultrasound–guided ...